Arterys Receives First FDA Clearance for Broad Oncology Imaging Suite with Deep Learning

FDA clearance covers all solid tumors. Initial launch will include Liver AI and Lung AI oncology software to empower clinicians to quickly measure and track lesions and nodules in MRI and CT scans SAN FRANCISCO, Feb. 15, 2018 -- (Healthcare Sales & Mark... Devices, Radiology, Oncology, FDA Arterys, imaging, artificial intelligence
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news